Concomitant Radio-chemotherapy in the Elderly

Sponsor
University Hospital, Limoges
Study ID
NCT01029678
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
70 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cisplatin IV — DRUG
    Cisplatin IV 30 mg/m2/ (Day 1, Day 8, Day 15, Day 22, Day 29, Day 36)
  • Vinorelbine — DRUG
    Vinorelbine per os 30 mg/m2/(day1, day8, day15, day22, day29, day36
  • Radiotherapy — RADIATION
    66Gy, 33 fractions, 6 week

Study Details

The purpose of this study is to evaluate the safety of non small cell lung cancer (NSCLC) treatment with cisplatin and oral vinorelbine administered weekly associated with concomitant radiotherapy in elderly patients.

Key Dates

Start date
Jan 31, 2010
Status verified
Jan 2018
Primary completion
Jan 31, 2015
Completion
Jun 30, 2016

Study Design

Enrollment
48 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: experimental

Primary Outcome Measure

Acute toxicity [ Time Frame: during treatment and during the 4 weeks following the end of treatment ]

Related Studies